AIM ImmunoTech Inc. reports positive data from Phase 2a stud

AIM ImmunoTech Inc. reports positive data from Phase 2a study evaluating Ampligen as a part of a regimen for treating colorectal cancer metastatic to the liver

AIM ImmunoTech Inc. reports positive data from Phase 2a study evaluating Ampligen as a part of a regimen for treating colorectal cancer metastatic to the liver
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Florida , United States , Louisiana , New Orleans , Ocala , American , Pawel Kalinski , Davidr Strayer , Roswell Park , Sarbajit Mukherjee , Roswell Park Comprehensive Cancer Center , American Association For Cancer Research , Immunotech Inc , Tech Inc , Chemokine Modulatory , American Association , Cancer Research ,